MCV5 (Meningococcal Conjugate Vaccine Containing Serogroups A, C, Y, W, and X)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MCV5 (Meningococcal Conjugate Vaccine Containing Serogroups A, C, Y, W, and X), covering 2021-03-30 to 2021-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults [Phase 1]